Jci_page_head_homepage_01 Jci_page_head_homepage_02
Sara K. Hansen, Marcelina Párrizas, Maria L. Jensen, Stepanka Pruhova, Jakob Ek, Sylvia F. Boj, Anders Johansen, Miguel A. Maestro, Francisca Rivera, Hans Eiberg, Michal Andel, Jan Lebl, Oluf Pedersen, Jorge Ferrer, Torben Hansen
Published in Volume 110, Issue 6
J Clin Invest. 2002; 110(6):827–833 doi:10.1172/JCI15085
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4

Effect of P2 promoter mutations on HNF-1α–dependent activation. (a) Schematic representation of the P2 promoter plasmids used in the transfection experiments described. Positions of the HNF1 site and the previously reported TAAT box are depicted. (b) Cotransfection of fibroblasts with indicated reporter constructs plus increasing amounts (0.05–10 ng) of pBJ5-HNF1α. Data are expressed as percentages of transfections performed with empty pBJ5. (c) Effect of DCoH on HNF-1α–dependent activation of indicated constructs. (d) Effect of HNF1G→A and HNF1→SAC mutations in cell lines expressing endogenous HNF-1α. Data are expressed as percentages of results obtained with P2.371. *P < 0.05; **P < 0.01.